From: S100A6 inhibits MDM2 to suppress breast cancer growth and enhance sensitivity to chemotherapy
Variable | pCR rate (%) | Univariate analysis P value | Multivariate analysis P value |
---|---|---|---|
S100A6 (high/low) | 41.8%/11.5% |  < 0.0001 | 0.010 |
MDM2 (high/low) | 15.4%/33.8% |  < 0.0001 | 0.215 |
Size (pT1-2/pT3-4) | 27.2%/27.0% | 0.680 | 0.757 |
Histological grade (I–II/III) | 24.7%/33.3% | 0.300 | 0.543 |
LN metastasis (posi/neg) | 27.7%/25.0% | 0.882 | 0.679 |
MIB (< 10%/ ≥ 10%) | 12.5%/29.7% | 0.177 | 0.664 |
ERα (posi/neg) | 19.1%/38.6% | 0.045 | 0.798 |
PR (posi/neg) | 21.3%/34.8% | 0.188 | 0.294 |
Her2 (posi/neg) | 47.8%/21.4% | 0.008 | 0.001 |
Molecular subtype (TNBC/others) | 44.4%/21.3% | 0.046 | 0.011 |